IQVIA Holdings Inc. logo
IQVIA Holdings Inc. (IQV)
Compare

IQVIA Holdings Inc. (IQV) Earnings Yield: 4.40%

Is IQVIA Holdings Inc.’s earnings yield high or low?

IQVIA Holdings Inc.'s earnings yield of 4.40% is 46% above its 5-year average of 3.02%, near the high end of its 5-year range (0.83%–5.36%).

The earnings yield for IQVIA Holdings Inc. (IQV) is 4.40% as of Wednesday, June 10, 2026. It is above its 12-month average by 11.39% (3.95%).

IQV Earnings Yield Chart

IQV Earnings Yield
4.40%-4.14% 1Y
Zoom

IQV Average Earnings Yield Chart

IQV Current vs Average Earnings Yield Chart

IQV Earnings Yield Metrics

EARNINGS YIELD

4.40%

EARNINGS YIELD AVG TTM

3.95%

EARNINGS YIELD AVG 3Y

3.55%

EARNINGS YIELD AVG 5Y

3.02%

EARNINGS YIELD AVG 10Y

2.62%

EARNINGS YIELD AVG 15Y

2.92%

EARNINGS YIELD AVG 20Y

2.92%

CURRENT VS TTM AVG

+11.39%

CURRENT VS 3Y AVG

+23.93%

CURRENT VS 5Y AVG

+45.69%

CURRENT VS 10Y AVG

+68.20%

CURRENT VS 15Y AVG

+50.65%

CURRENT VS 20Y AVG

+50.65%

IQV Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
IQVIA Holdings Inc. (IQV)$30.60B4.40%3.95%3.55%3.02%
Medline Inc. (MDLN)$30.90B3.31%3.20%3.20%3.20%
Centene Corporation (CNC)$31.94BN/A11.79%7.73%6.10%
DexCom, Inc. (DXCM)$29.24B3.09%2.56%1.80%1.31%
Biogen Inc. (BIIB)$29.00B4.75%6.30%5.94%5.80%
Zoetis Inc. (ZTS)$34.20B7.40%4.72%3.52%3.07%
Veeva Systems Inc. (VEEV)$26.73B3.43%2.29%1.91%1.65%
Agilent Technologies, Inc. (A)$37.17B3.78%3.45%3.39%3.16%
Waters Corporation (WAT)$23.83B2.15%3.21%3.32%3.36%
Mettler-Toledo International Inc. (MTD)$22.85B3.77%3.16%3.10%2.84%

Earnings Yield vs P/E Ratio

Earnings Yield

4.40%

EPS ÷ Price

P/E Ratio

22.7

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

IQVIA Holdings Inc. Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IQVIA Holdings Inc. Earnings Yield FAQ

What is the earnings yield for IQVIA Holdings Inc. (IQV)?
The earnings yield for IQV stock is 4.40%.
Is IQVIA Holdings Inc.'s earnings yield high or low?
IQVIA Holdings Inc.'s earnings yield of 4.40% is 46% above its 5-year average of 3.02%, near the high end of its 5-year range (0.83%–5.36%).
What is the TTM average earnings yield for IQVIA Holdings Inc. (IQV)?
The TTM average earnings yield for IQV stock is 3.95%.
What is the 3Y average earnings yield for IQVIA Holdings Inc. (IQV)?
The 3Y average earnings yield for IQV stock is 3.55%.
What is the 5Y average earnings yield for IQVIA Holdings Inc. (IQV)?
The 5Y average earnings yield for IQV stock is 3.02%.
What is the 10Y average earnings yield for IQVIA Holdings Inc. (IQV)?
The 10Y average earnings yield for IQV stock is 2.62%.
What is the 15Y average earnings yield for IQVIA Holdings Inc. (IQV)?
The 15Y average earnings yield for IQV stock is 2.92%.
What is the 20Y average earnings yield for IQVIA Holdings Inc. (IQV)?
The 20Y average earnings yield for IQV stock is 2.92%.

IQVIA Holdings Inc. Earnings Yield History

DATEEARNINGS YIELD
2026-06-104.40%
2026-06-094.33%
2026-06-084.39%
2026-06-054.40%
2026-06-044.32%
2026-06-034.43%
2026-06-024.47%
2026-06-014.32%
2026-05-294.43%
2026-05-284.46%
2026-05-274.87%
2026-05-264.98%
2026-05-224.81%
2026-05-214.80%
2026-05-204.71%
2026-05-194.66%
2026-05-184.67%
2026-05-154.77%
2026-05-144.73%
2026-05-134.68%
2026-05-124.61%
2026-05-114.65%
2026-05-084.52%
2026-05-074.52%
2026-05-064.57%
2026-05-054.57%
2026-05-044.88%
2026-05-014.98%
2026-04-304.96%
2026-04-295.02%
2026-04-284.94%
2026-04-274.80%
2026-04-244.84%
2026-04-234.89%
2026-04-224.49%
2026-04-214.47%
2026-04-204.45%
2026-04-174.45%
2026-04-164.57%
2026-04-154.41%
2026-04-144.48%
2026-04-134.57%
2026-04-104.70%
2026-04-094.65%
2026-04-084.56%
2026-04-074.61%
2026-04-064.60%
2026-04-024.54%
2026-04-014.56%
2026-03-314.61%
2026-03-304.73%
2026-03-274.80%
2026-03-264.64%
2026-03-254.75%
2026-03-244.73%
2026-03-234.71%
2026-03-204.73%
2026-03-194.72%
2026-03-184.71%
2026-03-174.67%
2026-03-164.77%
2026-03-134.77%
2026-03-124.82%
2026-03-114.58%
2026-03-104.60%
2026-03-094.40%
2026-03-064.50%
2026-03-054.40%
2026-03-044.42%
2026-03-034.52%
2026-03-024.51%
2026-02-274.40%
2026-02-264.61%
2026-02-254.85%
2026-02-244.77%
2026-02-234.84%
2026-02-204.75%
2026-02-194.64%
2026-02-184.60%
2026-02-174.78%
2026-02-134.37%
2026-02-124.32%
2026-02-114.12%
2026-02-104.00%
2026-02-093.78%
2026-02-063.89%
2026-02-054.03%
2026-02-043.60%
2026-02-033.58%
2026-02-023.15%
2026-01-303.17%
2026-01-293.09%
2026-01-283.04%
2026-01-273.02%
2026-01-263.05%
2026-01-233.10%
2026-01-223.05%
2026-01-213.02%
2026-01-203.12%
2026-01-163.07%
2026-01-153.02%
2026-01-143.02%
2026-01-133.02%
2026-01-123.03%
2026-01-093.01%
2026-01-083.00%
2026-01-072.98%
2026-01-063.03%
2026-01-053.11%
2026-01-023.24%
2025-12-313.23%
2025-12-303.20%
2025-12-293.21%
2025-12-263.21%
2025-12-243.23%
2025-12-233.24%
2025-12-223.25%
2025-12-193.30%
2025-12-183.28%
2025-12-173.29%
2025-12-163.29%
2025-12-153.26%
2025-12-123.28%
2025-12-113.23%
2025-12-103.27%
2025-12-093.34%
2025-12-083.26%
2025-12-053.23%
2025-12-043.24%
2025-12-033.21%
2025-12-023.23%
2025-12-013.19%
2025-11-283.17%
2025-11-263.14%
2025-11-253.14%
2025-11-243.19%
2025-11-213.24%
2025-11-203.36%
2025-11-193.35%
2025-11-183.35%
2025-11-173.37%
2025-11-143.30%
2025-11-133.26%
2025-11-123.30%
2025-11-113.34%
2025-11-103.42%
2025-11-073.46%
2025-11-063.46%
2025-11-053.47%
2025-11-043.46%
2025-11-033.41%
2025-10-313.37%
2025-10-303.37%
2025-10-293.35%
2025-10-283.34%
2025-10-273.18%
2025-10-243.13%
2025-10-233.14%
2025-10-223.17%
2025-10-213.16%
2025-10-203.26%
2025-10-173.38%
2025-10-163.36%
2025-10-153.40%
2025-10-143.37%
2025-10-133.39%
2025-10-103.49%
2025-10-093.40%
2025-10-083.44%
2025-10-073.44%
2025-10-063.37%
2025-10-033.34%
2025-10-023.38%
2025-10-013.39%
2025-09-303.64%
2025-09-293.82%
2025-09-263.85%
2025-09-253.91%
2025-09-243.81%
2025-09-233.71%
2025-09-223.68%
2025-09-193.69%
2025-09-183.63%
2025-09-173.70%
2025-09-163.70%
2025-09-153.72%
2025-09-123.69%
2025-09-113.62%
2025-09-103.76%
2025-09-093.64%
2025-09-083.68%
2025-09-053.68%
2025-09-043.75%
2025-09-033.74%
2025-09-023.76%
2025-08-293.62%
2025-08-283.66%
2025-08-273.66%
2025-08-263.68%
2025-08-253.68%
2025-08-223.62%
2025-08-213.73%
2025-08-203.60%
2025-08-193.59%
2025-08-183.59%
2025-08-153.62%
2025-08-143.65%
2025-08-133.63%
2025-08-123.72%
2025-08-113.84%
2025-08-083.84%
2025-08-073.86%
2025-08-063.89%
2025-08-053.76%
2025-08-043.78%
2025-08-013.79%
2025-07-313.72%
2025-07-303.61%
2025-07-293.55%
2025-07-283.49%
2025-07-253.47%
2025-07-243.44%
2025-07-233.56%
2025-07-223.69%
2025-07-214.62%
2025-07-184.57%
2025-07-174.50%
2025-07-164.63%
2025-07-154.66%
2025-07-144.58%
2025-07-114.51%
2025-07-104.43%
2025-07-094.53%
2025-07-084.46%
2025-07-074.52%
2025-07-034.47%
2025-07-024.46%
2025-07-014.51%
2025-06-304.66%
2025-06-274.66%
2025-06-264.64%
2025-06-254.63%
2025-06-244.63%
2025-06-234.73%
2025-06-204.74%
2025-06-184.75%
2025-06-174.76%
2025-06-164.61%
2025-06-134.68%
2025-06-124.61%
2025-06-114.62%
2025-06-104.59%
2025-06-094.76%
2025-06-064.82%
2025-06-054.98%
2025-06-044.96%
2025-06-035.14%
2025-06-025.28%
2025-05-305.23%
2025-05-295.21%

Showing the most recent 260 of 3,292 data points. The chart above shows the full history.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC
89,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ari Bousbib